A FAMILIAL DEFICIENCY OF PHAGOCYTOSIS-ENHANCING ACTIVITY OF SERUM RELATED TO A DYSFUNCTION OF FIFTH COMPONENT OF COMPLEMENT (C5)

被引：245
|
作者：
MILLER, ME
NILSSON, UR
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1970年 / 282卷 / 07期
关键词：
D O I：
10.1056/NEJM197002122820702
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：354 / &
相关论文
共 50 条
  • [31] THE LOW C5 CONVERTASE ACTIVITY OF THE C4A6 ALLOTYPE OF HUMAN-COMPLEMENT COMPONENT C-4
    KINOSHITA, T
    DODDS, AW
    LAW, SKA
    INOUE, K
    BIOCHEMICAL JOURNAL, 1989, 261 (03) : 743 - 748
  • [32] The complement component C5 is not responsible for the alternative pathway activity in rabbit erythrocyte hemolytic assays during eculizumab treatment
    Lambertus P. van den Heuvel
    Nicole C. A. J. van de Kar
    Caroline Duineveld
    Andrei Sarlea
    Thea J. A. M. van der Velden
    Wilhelmus T. B. Liebrand
    Sanne van Kraaij
    Camilla Schjalm
    Romy Bouwmeester
    Jack F. M. Wetzels
    Tom E. Mollnes
    Elena B. Volokhina
    Cellular & Molecular Immunology, 2020, 17 : 653 - 655
  • [33] The complement component C5 is not responsible for the alternative pathway activity in rabbit erythrocyte hemolytic assays during eculizumab treatment
    van den Heuvel, Lambertus P.
    van de Kar, Nicole C. A. J.
    Duineveld, Caroline
    Sarlea, Andrei
    van der Velden, Thea J. A. M.
    Liebrand, Wilhelmus T. B.
    van Kraaij, Sanne
    Schjalm, Camilla
    Bouwmeester, Romy
    Wetzels, Jack F. M.
    Mollnes, Tom E.
    Volokhina, Elena B.
    CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (06) : 653 - 655
  • [34] SPECIFIC INHIBITOR OF COMPLEMENT (C5)-DERIVED CHEMOTACTIC ACTIVITY IN SERUM FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    PEREZ, HD
    LIPTON, M
    GOLDSTEIN, IM
    JOURNAL OF CLINICAL INVESTIGATION, 1978, 62 (01): : 29 - 38
  • [35] SPECIFIC INHIBITOR OF COMPLEMENT (C5)-DERIVED CHEMOTACTIC ACTIVITY IN SERUM FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    PEREZ, HD
    LIPTON, M
    GOLDSTEIN, IM
    CLINICAL RESEARCH, 1978, 26 (03): : A519 - A519
  • [36] In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway
    Ispasanie, Emma
    Muri, Lukas
    Schmid, Marc
    Schubart, Anna
    Thorburn, Christine
    Zamurovic, Natasa
    Holbro, Thomas
    Kammueller, Michael
    Pluschke, Gerd
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [37] MECHANISM OF ACTION OF A SPECIFIC INHIBITOR OF COMPLEMENT (C5)-DERIVED CHEMOTACTIC ACTIVITY IN SERUM FROM PATIENTS WITH LUPUS-ERYTHEMATOSUS
    PEREZ, HD
    GOLDSTEIN, IM
    ANDRON, R
    CHERNOFF, D
    CLINICAL RESEARCH, 1979, 27 (02): : A333 - A333
  • [38] SPECIFIC INHIBITOR OF COMPLEMENT (C5)-DERIVED CHEMOTACTIC ACTIVITY IN SERUM FROM PATIENTS WITH ACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS
    PEREZ, HD
    LIPTON, M
    GOLDSTEIN, IM
    ARTHRITIS AND RHEUMATISM, 1978, 21 (05): : 583 - 583
  • [39] Comparative Evaluation of Complement Factor D, C3, and C5 Inhibitors on Serum Bactericidal Activity Against Neisseria Meningitidis Isolates
    Zhao, Yongsen
    Patel, Dharaben
    Thanassi, Jane A.
    Huang, Mingjun
    Podos, Steven D.
    BLOOD, 2019, 134
  • [40] COMPARATIVE EVALUATION OF COMPLEMENT FACTOR D, C3, AND C5 INHIBITORS ON SERUM BACTERICIDAL ACTIVITY AGAINST NEISSERIA MENINGITIDIS ISOLATES
    Zhao, Yongsen
    Patel, Dharaben
    Thanassi, Jane
    Huang, Mingjun
    Podos, Steven
    MOLECULAR IMMUNOLOGY, 2019, 114 : 489 - 490
12345